Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Front Immunol. 2020 Jul 7;11:1337. doi: 10.3389/fimmu.2020.01337. eCollection 2020.
Autophagy is a cellular recycling system found in almost all types of eukaryotic organisms. The system is made up of a variety of proteins which function to deliver intracellular cargo to lysosomes for formation of autophagosomes in which the contents are degraded. The maintenance of cellular homeostasis is key in the survival and function of a variety of human cell populations. The interconnection between metabolism and autophagy is extensive, therefore it has a role in a variety of different cell functions. The disruption or dysfunction of autophagy in these cell types have been implicated in the development of a variety of inflammatory diseases including asthma. The role of autophagy in non-immune and immune cells both lead to the pathogenesis of lung inflammation. Autophagy in pulmonary non-immune cells leads to tissue remodeling which can develop into chronic asthma cases with long term effects. The role autophagy in the lymphoid and myeloid lineages in the pathology of asthma differ in their functions. Impaired autophagy in lymphoid populations have been shown, in general, to decrease inflammation in both asthma and inflammatory disease models. Many lymphoid cells rely on autophagy for effector function and maintained inflammation. In stark contrast, autophagy deficient antigen presenting cells have been shown to have an activated inflammasome. This is largely characterized by a T17 response that is accompanied with a much worse prognosis including granulocyte mediated inflammation and steroid resistance. The cell specificity associated with changes in autophagic flux complicates its targeting for amelioration of asthmatic symptoms. Differing asthmatic phenotypes between T2 and T17 mediated disease may require different autophagic modulations. Therefore, treatments call for a more cell specific and personalized approach when looking at chronic asthma cases. Viral-induced lung inflammation, such as that caused by SARS-CoV-2, also may involve autophagic modulation leading to inflammation mediated by lung resident cells. In this review, we will be discussing the role of autophagy in non-immune cells, myeloid cells, and lymphoid cells for their implications into lung inflammation and asthma. Finally, we will discuss autophagy's role viral pathogenesis, immunometabolism, and asthma with insights into autophagic modulators for amelioration of lung inflammation.
自噬是一种存在于几乎所有真核生物中的细胞回收系统。该系统由多种蛋白质组成,其功能是将细胞内货物递送到溶酶体,形成自噬体,其中内容物被降解。细胞内稳态的维持是各种人类细胞群存活和功能的关键。代谢与自噬之间的联系非常广泛,因此它在各种不同的细胞功能中都有作用。这些细胞类型中自噬的破坏或功能障碍与多种炎症性疾病的发展有关,包括哮喘。自噬在非免疫和免疫细胞中的作用都导致了肺部炎症的发病机制。自噬在肺非免疫细胞中的作用导致组织重塑,可发展为慢性哮喘病例,具有长期影响。自噬在肺非免疫细胞和免疫细胞中的作用在其功能上有所不同。已表明,在哮喘和炎症性疾病模型中,淋巴样群体中的自噬受损通常会减少炎症。许多淋巴样细胞依赖自噬来发挥效应功能和维持炎症。与此形成鲜明对比的是,自噬缺陷的抗原呈递细胞已被证明具有激活的炎性体。这主要表现为 T17 反应,伴随着更糟糕的预后,包括粒细胞介导的炎症和类固醇耐药性。与自噬流变化相关的细胞特异性使靶向治疗哮喘症状变得复杂。T2 和 T17 介导的疾病之间不同的哮喘表型可能需要不同的自噬调节。因此,在治疗慢性哮喘病例时,需要采用更具细胞特异性和个性化的方法。病毒引起的肺部炎症,如 SARS-CoV-2 引起的肺部炎症,也可能涉及自噬调节,导致肺驻留细胞介导的炎症。在这篇综述中,我们将讨论自噬在非免疫细胞、髓样细胞和淋巴样细胞中的作用,以及它们对肺部炎症和哮喘的影响。最后,我们将讨论自噬在病毒发病机制、免疫代谢和哮喘中的作用,以及自噬调节剂在减轻肺部炎症方面的作用。